Skip to Content

Cerivastatin Pregnancy and Breastfeeding Warnings

Cerivastatin is also known as: Baycol

Cerivastatin Pregnancy Warnings

Cerivastatin has been assigned to pregnancy category X by the FDA. Animal studies have revealed evidence of teratogenicity, including an increase in the incidence of skeletal malformations. There are no controlled data in human pregnancy. However, HMG-CoA reductase inhibitors are known to inhibit biosynthetic processes necessary in fetal development. Rare cases of congenital anomalies have been reported following prenatal exposure to other HMG-CoA reductase inhibitors. Cerivastatin use is considered contraindicated during pregnancy.

The VATER association (vertebral anomalies, anal atresia, tracheo-esophageal fistula with esophageal atresia, renal and radial dysplasia) was reported in an infant girl whose mother received lovastatin 10 mg and dextroamphetamine 10 mg daily during the first trimester of pregnancy for the treatment of hypercholesterolemia and progressive weight gain. Both drugs were discontinued five weeks later, at approximately nine weeks gestation, when pregnancy was confirmed.

See references

Cerivastatin Breastfeeding Warnings

Cerivastatin is excreted into human milk. According to the manufacturer, the breast milk to plasma ratio of cerivastatin based on preclinical data is 1.3:1. The manufacturer recommends that due to the potential for serious adverse reactions in nursing infants, a decision should be made to discontinue nursing or discontinue the drug, taking into account the importance of the drug to the mother.

See references

References for pregnancy information

  1. Ghidini A, Sicherer S, Willner J "Congenital abnormalities (VATER) in baby born to mother using lovastatin ." Lancet 339 (1992): 1416-7
  2. "Product Information. Baycol (cerivastatin)." Bayer, West Haven, CT.

References for breastfeeding information

  1. "Product Information. Baycol (cerivastatin)." Bayer, West Haven, CT.

Disclaimer: Every effort has been made to ensure that the information provided by Cerner Multum, Wolters Kluwer Health and is accurate, up-to-date and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This material does not endorse drugs, diagnose patients, or recommend therapy. This drug information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Multum Information Services, Inc. does not assume any responsibility for any aspect of healthcare administered with the aid of information Multum provides. Copyright 2000-2008 Multum Information Services, Inc. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse, or pharmacist.